Femtrace Warner Chilcott - Treatment for Menopausal Vasomotor Symptoms
Femtrace has been approved for the relief of the vasomotor symptoms of menopause. Approval was not granted for the secondary indication of vulvar-vaginal atrophy. The comapny expects to launch Femtrace in the first quarter of 2005.Posted: August 2004

